Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hull

Showing results (141-150 of 699) with videos related to

Pageof 70
Sort By:
Current Opinion in Pulmonary Medicine|July 17, 1999
Disorders of pulmonary circulationG F Pineo, R D Hull
Hematology/Oncology Clinics of North America|January 11, 2005
Vitamin K antagonists and direct thrombin inhibitors: present and futureGraham F Pineo, Russell D Hull
European Journal of Medical Research|June 24, 2004
Dalteparin: pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic diseasesGraham F Pineo, Russell D Hull
Seminars in Thrombosis and Hemostasis|January 1, 1994
Therapeutic use of low molecular weight heparins: knowledge to date and their application to therapyR D Hull, G F Pineo
Chest|September 1, 1994
Relative risks of anticoagulant treatment of acute pulmonary embolism based on an angiographic diagnosis vs a ventilation/perfusion scan diagnosisP D Stein, R D Hull
Cancer Treatment and Research|April 21, 2009
Effects of anticoagulants on cancer: heparinsGraham F Pineo, Russell D Hull
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 13, 2009
Economic and practical aspects of thromboprophylaxis with unfractionated and low-molecular-weight heparins in hospitalized medical patientsGraham F Pineo, Russell D Hull
Population Health Management|February 15, 2013
Factors associated with participation in and benefits of a worksite wellness programRay M Merrill, John D Hull
Current Medical Research and Opinion|October 10, 2014
The current landscape of treatment options for venous thromboembolism: a focus on novel oral anticoagulantsRussell D Hull, Meryl H Gersh
Seminars in Thrombosis and Hemostasis|January 1, 1993
Therapeutic use of low molecular weight heparins: the knowledge to date as applied to therapyR D Hull, G F Pineo
Pageof 70

Showing results (141-150 of 699) with videos related to

Sort By:
Pageof 70
Current Opinion in Pulmonary Medicine|July 17, 1999
Disorders of pulmonary circulationG F Pineo, R D Hull
Hematology/Oncology Clinics of North America|January 11, 2005
Vitamin K antagonists and direct thrombin inhibitors: present and futureGraham F Pineo, Russell D Hull
European Journal of Medical Research|June 24, 2004
Dalteparin: pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic diseasesGraham F Pineo, Russell D Hull
Seminars in Thrombosis and Hemostasis|January 1, 1994
Therapeutic use of low molecular weight heparins: knowledge to date and their application to therapyR D Hull, G F Pineo
Chest|September 1, 1994
Relative risks of anticoagulant treatment of acute pulmonary embolism based on an angiographic diagnosis vs a ventilation/perfusion scan diagnosisP D Stein, R D Hull
Cancer Treatment and Research|April 21, 2009
Effects of anticoagulants on cancer: heparinsGraham F Pineo, Russell D Hull
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 13, 2009
Economic and practical aspects of thromboprophylaxis with unfractionated and low-molecular-weight heparins in hospitalized medical patientsGraham F Pineo, Russell D Hull
Population Health Management|February 15, 2013
Factors associated with participation in and benefits of a worksite wellness programRay M Merrill, John D Hull
Current Medical Research and Opinion|October 10, 2014
The current landscape of treatment options for venous thromboembolism: a focus on novel oral anticoagulantsRussell D Hull, Meryl H Gersh
Seminars in Thrombosis and Hemostasis|January 1, 1993
Therapeutic use of low molecular weight heparins: the knowledge to date as applied to therapyR D Hull, G F Pineo
Pageof 70